Navigation Links
More Retinal Detachment Seen With Higher Income Status
Date:9/29/2009

Findings shed no light on reason for link, Scottish researchers say

TUESDAY, Sept. 29 (HealthDay News) -- Wealthy people are twice as likely to suffer retinal detachment as poorer people, according to Scottish researchers who said they couldn't identify the reason for the disparity.

Retinal detachment -- the separation of the retina from its connection at the back of the eye -- usually occurs as a result of a tear in the retina. If patients don't receive immediate treatment, retinal detachment can lead to permanent vision loss.

The new study included 572 patients diagnosed with primary retinal detachment in Scotland over a one-year period between 2007 and 2008. The rate of retinal detachment was 15.4 per 100,000 population among the most affluent patients, compared with 13.6 per 100,000 for the second-most affluent patients, 9.3 per 100,000 for the third-most affluent patients, and 6.9 per 100,000 among the least affluent patients.

This was a surprising finding that's never been reported before, said Dr. David Yorston of Gartnavel General Hospital in Glasgow, and colleagues.

"We have not found any satisfactory explanation for the greater incidence of [retinal detachment] in less deprived patients. It is possible that a combination of small differences in known risk factors, such as myopia [short-sightedness] and previous cataract surgery account for the difference," they wrote. "However, we cannot exclude the possibility that affluence is associated with some other, hitherto, unknown risk factor."

The study appears online Sept. 29 in the British Journal of Ophthalmology.

More information

The U.S. National Eye Institute has more about retinal detachment.



-- Robert Preidt



SOURCE: BMJ Journals, news release, Sept. 28, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. MIT retinal implant could help restore some vision
2. Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration
3. In retinal disease, sight may depend on second sites
4. Study reports success in treating a rare retinal disorder
5. Growth factor TGF-B helps maintain health of retinal blood vessels
6. Eye Cells Believed to Be Retinal Stem Cells Are Misidentified
7. Retinal Gene Is Linked to Childhood Blindness
8. Cell death from cytomegalovirus may bring new life to treatment of retinal disease
9. CA$2.4 million toward gene therapy for human degenerative retinal diseases
10. Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution
11. Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... 2017 , ... The StayWell Company announced today that it ... StayWell’s asthma, coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease, and ... programs for the delivery and improvement of disease management and that meet or ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... and businesses of the greater Fort Collins area, has unveiled a collaboration with ... community involvement program. Donations to this worthy cause may now be made at ...
(Date:3/23/2017)... ... March 23, 2017 , ... ?This conference will prominently feature 150+ Hospital and Health ... Director, AMN Healthcare: Susan Salka , 43rd President of the United States of ... Fight My Life In and Out of the Ring: Sugar Ray Leonard , ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, a company known ... health and nutrition, announced its product Leyzene is now available for purchase on ... supplements that help people improve all aspects of their health so they can ...
(Date:3/23/2017)... ... 2017 , ... The American Board of Quality Assurance and Utilization Review Physicians ... to Health Care Quality and Management and Patient Safety. , It is with appreciation ... but also to the Health Care Quality and Patient Safety movements. Diplomates and Members ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017 Merrimack Pharmaceuticals, Inc. (NASDAQ: ... its first patient in a Phase 1 study of ... (ADN) that encapsulates a novel taxane and targets the ... in 50-100% of many major tumor types, including prostate, ... "The initiation of this study is an important step ...
(Date:3/23/2017)... WINNIPEG , March 23, 2017 /PRNewswire/ - ... a leading Canadian specialty pharmaceutical company, is pleased ... has received final approval from the U.S. Food ... new drug application ("ANDA") for tetrabenazine tablets in ... newly approved product is a generic equivalent of ...
(Date:3/23/2017)... SANTA MONICA, Calif. , March 23, 2017 /PRNewswire/ ... the launch of a native mobile app for the ... the standard for surgery coordination and communication for physician ... of a native mobile app offers iPhone users even ... "Casetabs is making it even easier to connect ...
Breaking Medicine Technology: